cephalosporin c has been researched along with zithromax in 124 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 23 (18.55) | 18.2507 |
| 2000's | 40 (32.26) | 29.6817 |
| 2010's | 38 (30.65) | 24.3611 |
| 2020's | 23 (18.55) | 2.80 |
| Authors | Studies |
|---|---|
| Biasi, D; Lunardi, C; Maleknia, T; Pacor, ML | 1 |
| Rodriguez, WJ; Wiedermann, BL | 1 |
| Johnson, RB; Martin, DH; McCormack, WM; Sargent, SJ; Spier, NA; Wendel, GD | 1 |
| Abeck, D; Ballard, RC | 1 |
| Conte, JE; Duncan, S; Golden, J; Lin, E; McKenna, E; Zurlinden, E | 1 |
| Cellesi, C; Chigiotti, S; Corbisiero, R; Mencarelli, M; Rossolini, GM; Zanchi, A | 1 |
| Rodriguez, AF | 1 |
| O'Doherty, B | 1 |
| Montero, L | 1 |
| Brookings, E; Gray, B; Swiatlo, E; Waites, K | 1 |
| Dudle, G; Lüthy, R; Opravil, M; Weber, R | 1 |
| Hildes-Ripstein, GE; Klassen, TP; Kozyrskyj, AL; Longstaffe, SE; Moffatt, ME; Sitar, DS; Wincott, JL | 1 |
| Braveny, I; Cremer, J; Milatovic, D; Wallrauch, C | 1 |
| Esparcia Navarro, M; García Callejo, FJ; Orts Alborch, MH; Pardo Mateu, L; Velert Vila, MM | 1 |
| Dagan, R; Fliss, DM; Greenberg, D; Leiberman, A; Leibovitz, E; Yagupsky, P | 1 |
| Katosova, LK; Platonova, MM; Sereda, EV | 1 |
| Johnson, DM; Jones, RN; Pfaller, MA | 1 |
| Lacy, MK; Nicolau, DP; Nightingale, CH; Owens, RC; Quintiliani, R; Xu, X | 1 |
| Arcidiacono, MM; Demartini, G; Dugnani, S; Fraschini, F; Pintucci, JP; Scaglione, F | 1 |
| Chiu, CH; Lin, TY; Ou, JT | 1 |
| Alvarez Gutiérrez, FJ; Calderón Osuna, E; Castillo Gómez, J; del Castillo Otero, D; Rodríguez Becerra, E; Sánchez Gómez, J; Soto Campos, G | 1 |
| Banevicius, MA; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
| Debbia, EA | 1 |
| Angelilli, ML; Matsui, DM; Rieder, MJ; Toscani, M | 1 |
| Alfonso Farnós, I; Alvarez Ruiz, S; Canut Blasco, A; Novales Salcedo, JL | 1 |
| Bates, J; File, TM; Grayston, JT; Indorf, A; Phillips, J; Sarosi, GA; Summersgill, J; Tan, J; Vergis, EN; YU, VL | 1 |
| Gomperts, BN; White, LK | 1 |
| Erhardt, W; Knirsch, C; Murphy, M | 1 |
| See, S | 1 |
| Bellussi, L; Boccazzi, A; Careddu, P; De'Angelis, M; Passali, D; Tonelli, P | 1 |
| Appelbaum, PC; Davies, TA; Dewasse, BE; Jacobs, MR; Nagai, K; Pankuch, GA | 1 |
| Gooch, WM; Oddo, LP; Powers, JL | 1 |
| Gerber, MA; Tanz, RR | 1 |
| Bogdanov, MB; Chernen'kaia, TV | 1 |
| Bruckner, DA; Lechner, A | 1 |
| Dillon, JA; Li, H; Prabhakar, P; Ruben, M; Sealy, J | 1 |
| Brown, A; Camara, B; Castor, D; Furlonge, C; Jolly, PE; Prabhakar, P; Rao, A; Weiss, H | 1 |
| Oksi, J | 1 |
| Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
| Duff, P | 1 |
| Mohler, AM | 1 |
| Appelbaum, PC; Bozdogan, B; Clark, C; Dewasse, B; Jacobs, MR; Peric, M | 1 |
| Brook, I | 1 |
| Fukuda, Y; Futakuchi, N; Kamiyama, T; Maekawa, M; Mitsuyama, J; Sugiura, Y; Takahata, M | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yamanaka, N; Yoshimori, K | 1 |
| Ahel, V; Averchenkova, L; Palcevski, G; Ratchina, S; Rosovic-Bazijanac, V; Vlahović-Palcevski, V | 1 |
| Parry, CM | 1 |
| Collet, JP; LeLorier, J; Quach, C | 1 |
| Kropp, R; Mann, J; Romanowski, B; Venne, S; Wong, T | 1 |
| Block, SL; Cifaldi, M; Gu, Y; Paris, MM | 1 |
| Dagan, R; Regev-Yochay, G; Rubinstein, E | 1 |
| Chiu, YL; Holas, C; Kapral, D; Notario, G | 1 |
| Mazereeuw-Hautier, J | 1 |
| Appelbaum, PC; Bogdanovich, T; Clark, C; Ednie, L; Lin, G; Shapiro, S; Smith, K | 1 |
| Blumer, JL; Dul, M; O'Riordan, MA; Toltzis, H; Toltzis, P | 1 |
| Conner, SM; del Rio, C; Harvey, AB; Holmes, KK; Judson, FN; Knapp, JS; Wang, SA; Whittington, WL; Zaidi, AA | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Hasan, AS; Nair, D; Pillai, P; Rawat, D | 1 |
| Andrews, WW; Grimes, A; Hauth, JC; Owen, J; Stamm, AM; Tita, AT | 2 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Noguchi, Y | 1 |
| Juan, C; Maciá, MD; Mena, A; Mulet, X; Oliver, A; Pérez, JL | 1 |
| Higashi, T; Ichikawa, Y; Koga, T; Matsuo, K; Nakamura, M; Rikimaru, T; Tokunaga, N | 1 |
| Abele-Horn, M; Frosch, M; Müller, S; Tappe, D; Valenza, G | 1 |
| Ison, CA | 1 |
| Donovan, B; Goire, N; Lahra, MM; Limnios, AE; Nissen, MD; Sloots, TP; Whiley, DM | 1 |
| Adelson, ME; Balashov, S; Gygax, SE; Mordechai, E | 1 |
| Gilbert, M; Hoang, LM; Hottes, TS; Imperial, M; Lester, RT; Martin, I; McKay, R; Ogilvie, G; Patrick, D; Wong, T | 1 |
| Arvai, M; Kárpáti, S; Marschalkó, M; Mihalik, N; Ostorházi, E | 1 |
| Drews, SJ; Gratrix, J; Lovgren, M; Martin, I; Read, R; Romanowski, B; Singh, AE; Sutherland, K; Talbot, J | 1 |
| de Melo Oliveira, MD; Hauser, P; Kovari, H; Läuchli, S; Meyer, J; Weber, R; Zbinden, R | 1 |
| Bauer, HM; Dixon, P; Gose, S; Kong, CJ; Lee, Y; Lei, J; Pandori, M; Samuel, MC; Soge, OO | 1 |
| Endimiani, A; Furrer, H; Guilarte, YN; Hauser, C; Hirzberger, L; Lupo, A; Selvini, S; Tinguely, R | 1 |
| Barbee, LA | 1 |
| Bauer, H; Bernstein, K; Castro, L; Chung, K; Gose, S; Nguyen, D; Pandori, M; Samuel, M | 1 |
| Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Unemo, M; Van de Laar, M | 1 |
| Bernstein, KT; Eaglin, M; Golden, M; Kerani, RP; Reed, M; Samuel, MC; Schumacher, C; Stenger, MR; Weinstock, H | 1 |
| Bánvölgyi, A; Brunner, A; Nemes-Nikodém, É; Ostorházi, E; Tóth, B; Tóth, V | 1 |
| Rice, LB | 1 |
| Friedman, DS; Gratrix, J; Hoang, L; Lester, R; Martin, I; Metz, G; Ogilvie, G; Read, R; Singh, AE; Wong, T | 1 |
| Allen, V; Archibald, C; Drews, S; Garceau, R; Haldane, D; Hoang, L; Horsman, G; Lefebvre, B; Liu, G; Martin, I; Mulvey, MR; Ratnam, S; Sawatzky, P; Wong, T; Wylie, J | 1 |
| Ab Rahman, N; Sivasampu, S; Teng, CL | 1 |
| Ignatius, R; Mertes, T; Regnath, T | 1 |
| Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N | 1 |
| Chai, X; Gao, X; Jiang, Z; Pan, G; Wang, Y; Yang, F; Zhao, X; Zhu, Y | 1 |
| de la Uz, CM; Kim, JJ; Miyake, CY; Moffett, BS; Niu, MC; Valdés, SO | 1 |
| Allan, RN; Coles, J; Collins, SA; Connett, GJ; Faust, SN; Feelisch, M; Hall-Stoodley, L; Halladay, GD; Jackson, CL; Kelso, MJ; Lucas, JS; Rineh, A; Walker, WT; Webb, JS; Yepuri, NR | 1 |
| Allan, RN; Brito-Mutunayagam, S; Clarke, SC; Faust, SN; Feelisch, M; Hall-Stoodley, L; Kelso, MJ; Rineh, A; Salib, RJ; Soren, O; Stoodley, P; Webb, JS; Yepuri, NR | 1 |
| Duarte, RV; Franik, S; Fuhrich, DG; Ross, J; Savaris, RF | 1 |
| Jiang, FX; Lan, Q; Le, WJ; Su, XH | 1 |
| Rathi, PM; Sonavane, AD | 1 |
| Caughey, AB; Niu, B; Skeith, AE; Tuuli, MG; Valent, AM | 1 |
| Demczuk, W; Haldane, D; Hoang, L; Labbé, AC; Lefebvre, B; Martin, I; Mulvey, MR; Naidu, P; Peterson, SW; Wylie, J | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Liu, YH | 1 |
| Crowley, B; Fennelly, N; Golparian, D; Lawlor, B; Mac Aogáin, M; Rose, L; Ryan, L; Unemo, M; Walsh, P | 1 |
| Cernela, N; Egli, A; Nüesch-Inderbinen, M; Stephan, R; Wüthrich, D | 1 |
| Duarte, RV; Franik, S; Fuhrich, DG; Ross, JDC; Savaris, RF | 1 |
| Calado, J; Campos, MJ; Castro, R; Lopes, Â; Pereira, F; Rocha, M | 1 |
| Abrams, AJ; Bernstein, K; Cartee, J; Cyr, SS; Gernert, KM; Hong, J; Kersh, EN; Lucking, S; Pham, CD; Schmerer, M; Seby, S; Shafer, WM; Thomas, JC; Torrone, E; Vidyaprakash, E | 1 |
| Gernert, KM; Kersh, EN; Raphael, BH; Shafer, WM; Thomas, JC | 1 |
| Deng, X; Klausner, JD | 1 |
| Clark, CM; Mergenhagen, KA; Russo, TA; Skelly, MK; Wattengel, BA | 1 |
| Cai, Y; Chen, S; Cheng, W; Huang, D; Mol, BW; Pan, H; Shen, Y; Shi, L; Shi, Y; Yu, J; Zeng, M; Zhang, J; Zhu, Q | 1 |
| Amicizia, D; Iovine, M; Lai, PL; Lecini, E; Marchini, F; Micale, RT; Panatto, D; Pennati, BM; Zangrillo, F | 1 |
| Benoit, JL; Farley, B; Frohne, C; Hazra, A; McNulty, M; Pettit, N; Pho, M; Pitrak, D; Pursell, K; Ridgway, JP; Saltzman, J; Schmitt, J; Uvin, AZ | 1 |
| Dong, N; Du, X; Jia, L; Li, Y; Liang, B; Liu, H; Ma, H; Qiu, S; Song, H; Sun, Y; Wang, J; Wu, F; Xia, S; Yang, C; Yang, X; Zhao, J | 1 |
| Li, Y; Peng, J; Wang, F; Xiu, L; Yin, Y; Zeng, Y; Zhang, C | 1 |
| Duarte, RV; Fuhrich, DG; Maissiat, J; Ross, J; Savaris, RF | 1 |
| Alexander, D; Allen, V; Barairo, N; Demczuk, W; Hatchette, TF; Hoang, L; Lefebvre, B; Martin, I; Mulvey, MR; Naidu, P; Peterson, SW; Tomas, K; Trubnikov, M; Wong, T | 1 |
| Buttazzi, R; Di Mario, S; Gagliotti, C; Moro, ML; Ricchizzi, E; Tedeschi, S | 1 |
| Alfsnes, K; Brynildsrud, OB; Caugant, DA; De Blasio, BF; Didelot, X; Eldholm, V; Korne-Elenbaas, J; Nilsen, ØJ; Osnes, MN; Syversen, G | 1 |
| Abdellati, S; Crucitti, T; De Baetselier, I; Kenyon, C; Laumen, JGE; Manoharan-Basil, SS; Martiny, D; Van Dijck, C | 1 |
| Christiaens, T; De Sutter, AI; Thorning, S; van Driel, ML | 1 |
| Gratrix, J; Martin, I; Mulvey, M; Naidu, P; Pilkie, D; Prasad, E; Sawatzky, P; Singh, A; Smyczek, PA; Wong, T | 1 |
| Cai, C; Cao, W; Chen, H; Guo, C; Li, M; Liao, Y; Lin, X; Liu, X; Pei, J; Qin, X; Tang, S; Wang, F; Wu, S; Wu, X; Wu, Z; Xie, Q; Yu, Y; Zheng, H | 1 |
| Hong, W; Hwang, TH; Jang, J; Jang, SP; Jang, SW; Kim, BO; Park, HW; Park, SK; Park, YK; Shin, J; Yang, W | 1 |
| Fang, HJ; Fu, CW; Han, MH; Jiang, Q; Tang, CX; Wang, HX; Wang, YP; Wu, JG | 1 |
| Cuadros, J; Galicia, P; Górgolas, M; Linares, M; Miguel-Benito, A; Pérez García, F; Ramos-Rincón, JM | 1 |
| Allerberger, F; Eigentler, A; Geusau, A; Hasenberger, P; Heger, F; Indra, A; Lippert, K; Pleininger, S; Ruppitsch, W; Schaeffer, J; Stadlbauer, S; Stöger, A | 1 |
| Baesu, A; Ballash, GA; Bayen, S; Lee, J; Lee, S; Mills, MC; Mollenkopf, DF; Sullivan, SMP; Wittum, TE | 1 |
| Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
| Guzel, M; Konyali, D; Soyer, Y | 1 |
| Hedin, K; Thorning, S; van Driel, ML | 1 |
23 review(s) available for cephalosporin c and zithromax
| Article | Year |
|---|---|
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
Chancroid.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Chancroid; Ciprofloxacin; Erythromycin; HIV Infections; Humans | 1996 |
Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis.
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Child; Drug Administration Schedule; Humans; Otitis Media; Randomized Controlled Trials as Topic; Treatment Outcome | 1998 |
[Antibiotic resistance: an always present problem].
Topics: Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Erythromycin; Haemophilus; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
New approaches to the treatment of group A streptococcal pharyngitis.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Humans; Penicillins; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Time Factors | 2001 |
[Diagnostics and treatment of Lyme borreliosis].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Azithromycin; Borrelia burgdorferi; Cephalosporins; Doxycycline; Erythema Chronicum Migrans; Humans; Lyme Disease; Penicillins; Polymerase Chain Reaction | 2000 |
Antibiotic selection in obstetrics: making cost-effective choices.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbapenems; Cephalosporins; Clindamycin; Cost-Benefit Analysis; Female; Fluoroquinolones; Humans; Linezolid; Metronidazole; Nitrofurantoin; Oxazolidinones; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Humans; Penicillins; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2002 |
The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam.
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Infective Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Infant; Infant, Newborn; Middle Aged; Nalidixic Acid; Treatment Outcome; Typhoid Fever; Vietnam | 2004 |
A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Patient Satisfaction; Randomized Controlled Trials as Topic; Single-Blind Method; Smell; Suspensions; Taste | 2005 |
[Impetigo].
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Azithromycin; Cephalosporins; Child; Clavulanic Acid; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin; Mupirocin; Ointments; Penicillins; Pregnancy; Pristinamycin; Sulfadiazine; Time Factors | 2006 |
[Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections].
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Cephalosporins; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Nucleic Acid Amplification Techniques; Ofloxacin; Pharyngitis; Pregnancy; Pregnancy Complications, Infectious; Sexual Behavior | 2009 |
Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Cephalosporins; Drug Resistance, Bacterial; Gonorrhea; Humans; Sexually Transmitted Diseases, Bacterial | 2012 |
The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactam Resistance; Cephalosporins; Gonorrhea; Humans; Neisseria gonorrhoeae; Public Health | 2012 |
Preparing for an era of untreatable gonorrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Administration Schedule; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharynx; Population Surveillance; Practice Guidelines as Topic; Public Health; Treatment Failure | 2014 |
Antibiotic therapy for pelvic inflammatory disease.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Clindamycin; Doxycycline; Female; Humans; Nitroimidazoles; Pelvic Inflammatory Disease; Publication Bias; Quinolones; Randomized Controlled Trials as Topic | 2017 |
Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Clindamycin; Doxycycline; Female; Humans; Metronidazole; Pelvic Inflammatory Disease; Quinolones; Randomized Controlled Trials as Topic | 2019 |
Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions.
Topics: Alcohols; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cephalosporins; Doxycycline; Drug Interactions; Erythromycin; Fluoroquinolones; Metronidazole; Penicillins; Tetracycline | 2020 |
Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Bicarbonates; Cephalosporins; Cholera; Cholera Vaccines; Ciprofloxacin; Drinking Water; Drug Resistance, Bacterial; Endemic Diseases; Epidemics; Europe; Global Burden of Disease; Glucose; Humans; Idarubicin; Potassium Chloride; Prednisone; Ringer's Lactate; Sanitation; Sodium Chloride; Travel; Travel Medicine; Travel-Related Illness; Typhoid Fever; Typhoid-Paratyphoid Vaccines; Vidarabine | 2019 |
Antibiotic therapy for pelvic inflammatory disease.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Clindamycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Nitroimidazoles; Pelvic Inflammatory Disease; Publication Bias; Quinolones; Randomized Controlled Trials as Topic | 2020 |
Different antibiotic treatments for group A streptococcal pharyngitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; Clindamycin; Humans; Infant; Macrolides; Middle Aged; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes; Sulfonamides; Young Adult | 2021 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
Different antibiotic treatments for group A streptococcal pharyngitis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Chronic Disease; Humans; Infant; Macrolides; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Recurrence; Streptococcus pyogenes; Systematic Reviews as Topic | 2023 |
21 trial(s) available for cephalosporin c and zithromax
| Article | Year |
|---|---|
[Safety of azithromycin in patients allergic to penicillin and cephalosporin].
Topics: Azithromycin; Cephalosporins; Humans; Immunoglobulin E; Penicillins; Skin Tests | 1994 |
Comparison of azithromycin and ceftriaxone for the treatment of chancroid.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Chancroid; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Injections, Intramuscular; Male; Prospective Studies; Treatment Outcome; Ulcer | 1995 |
An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media | 1996 |
An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1996 |
A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Male; Skin Diseases, Infectious; Soft Tissue Infections | 1996 |
Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
Topics: Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Child; Female; Humans; Male; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1998 |
[Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Clavulanic Acid; Female; Humans; Male; Maxillary Sinusitis; Otitis Media; Penicillins; Pharyngitis; Tonsillitis | 1998 |
Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bacteria; Cefaclor; Cephalosporins; Child, Preschool; Female; Humans; Infant; Male; Otitis Media with Effusion; Penicillins; Prospective Studies; Treatment Outcome | 1998 |
[Clinical significance of fungal and microbial associations and antibacterial therapy for treatment of chronic inflammatory respiratory tract diseases in children].
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Candida albicans; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Humans; Moraxella catarrhalis; Respiratory Tract Diseases; Streptococcus pneumoniae | 1998 |
Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Penicillin Resistance; Serum Bactericidal Test; Streptococcus pneumoniae | 1998 |
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Child; Exudates and Transudates; Female; Humans; Male; Otitis Media with Effusion; Time Factors | 1999 |
A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Cephalosporins; Enteritis; Female; Humans; Infant; Male; Prospective Studies; Salmonella Infections | 1999 |
[A randomized comparative study of 3 days of azithromycin treatment and 10 days of cefuroxime treatment in exacerbations in patients with chronic obstructive pulmonary disease].
Topics: Administration, Oral; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Chi-Square Distribution; Female; Follow-Up Studies; Humans; Lung Diseases, Obstructive; Male; Surveys and Questionnaires; Time Factors | 1999 |
Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia; Prospective Studies | 2000 |
Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Ceftibuten; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 2000 |
Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Single-Blind Method; Smell; Suspensions; Taste | 2000 |
A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
Topics: Acoustic Impedance Tests; Acute Disease; Administration, Oral; Analgesics; Analgesics, Non-Narcotic; Anti-Infective Agents; Anti-Inflammatory Agents; Azithromycin; Cefdinir; Cephalosporins; Child, Preschool; Diarrhea; Drug Administration Schedule; Female; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Male; Meningococcal Vaccines; Otitis Media; Pneumococcal Vaccines; Prospective Studies; Single-Blind Method; Streptococcus pneumoniae; Time Factors; Treatment Outcome; Tympanic Membrane | 2005 |
Comparative effects of single-dose ceftriaxone versus three oral antibiotic regimens on stool colonization by resistant bacilli in children.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefprozil; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance; Feces; Female; Gram-Negative Bacteria; Humans; Infant; Injections, Intramuscular; Male; Otitis Media | 2007 |
Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cephalosporins; Cesarean Section; Cohort Studies; Endometritis; Female; Humans; Longitudinal Studies; Pregnancy; Puerperal Infection; Retrospective Studies; Risk; Surgical Wound Infection | 2008 |
Evaluation of short-term clinical efficacy of 3-day therapy with azithromycin in comparison with 5-day cefcapene-pivoxyl for acute streptococcal tonsillopharyngitis in primary care.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Chi-Square Distribution; Drug Administration Schedule; Female; Humans; Male; Microbial Sensitivity Tests; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome; Young Adult | 2011 |
Efficacy of adjunctive azithromycin versus single-dose cephalosporin prophylaxis for caesarean scar defect: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cephalosporins; Cesarean Section; Cicatrix; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Postoperative Complications; Pregnancy; Pregnancy Complications, Infectious | 2020 |
80 other study(ies) available for cephalosporin c and zithromax
| Article | Year |
|---|---|
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Epithelium; Female; Humans; Male; Pulmonary Alveoli | 1996 |
Susceptibility of macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four-year period in central Italy.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactam Resistance; Ceftibuten; Ceftriaxone; Cephalosporins; Chi-Square Distribution; Erythromycin; Humans; Italy; Microbial Sensitivity Tests; Penicillin G; Streptococcus pyogenes | 1996 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Child; Clarithromycin; Clindamycin; Culture Media; Humans; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
[Meningitis after acute Borrelia burgdorferi infection in HIV infection].
Topics: Adult; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Azithromycin; Borrelia burgdorferi Group; Ceftriaxone; Cephalosporins; HIV Seropositivity; Humans; Immunocompromised Host; Immunoglobulin M; Insect Bites and Stings; Lyme Disease; Male; Meningitis, Bacterial; Pneumonia; Ticks | 1997 |
Antimicrobial interactions of trovafloxacin and extended-spectrum cephalosporins or azithromycin tested against clinical isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Topics: Anti-Infective Agents; Azithromycin; Cephalosporins; Drug Therapy, Combination; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Pseudomonas aeruginosa; Xanthomonas | 1998 |
Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Ceftazidime; Cephalosporins; Colony Count, Microbial; Drug Therapy, Combination; Humans; Mice; Pneumonia, Bacterial; Pseudomonas Infections; Survival Analysis; Time Factors; Urinary Tract Infections | 1999 |
Palatability of oral antibiotics among children in an urban primary care center.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Cefixime; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Flavoring Agents; Humans; Male; Pain Measurement; Patient Acceptance of Health Care; Taste; Urban Population | 2000 |
[A randomized, prospective and comparative study is a clinical trial].
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive | 2000 |
Gonococcal hand abscess.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Drainage; Female; Gonorrhea; Hand; Humans; Neisseria gonorrhoeae; Staining and Labeling | 2000 |
Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefaclor; Cephalosporins; Clinical Trials as Topic; Humans; Otitis Media; Outcome Assessment, Health Care; Time Factors; Treatment Outcome | 2000 |
Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Hospitalization; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic | 2000 |
In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Cefprozil; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Microbial Sensitivity Tests; Mutation; Serotyping; Streptococcus pneumoniae | 2000 |
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Community-Acquired Infections; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Inpatients; Penicillins; Pneumonia, Bacterial; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
Oligella ureolytica in blood culture: contaminant or infection?
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cefuroxime; Cephalosporins; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Pneumonia | 2001 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Guyana; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Prevalence; Saint Vincent and the Grenadines; Spectinomycin; Tetracycline Resistance; Trinidad and Tobago | 2001 |
Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gonorrhea; Health Behavior; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillinase; Penicillins; Prevalence; Spectinomycin; Tetracycline; Tetracycline Resistance; Trinidad and Tobago | 2001 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |
Treatment of streptococcal pharyngitis.
Topics: Anti-Bacterial Agents; Azithromycin; Cephalosporins; Humans; Penicillin Resistance; Pharyngitis; Streptococcal Infections | 2002 |
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
Topics: Amino Acid Sequence; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Genes, Bacterial; Haemophilus influenzae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial | 2002 |
[Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae].
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cephalosporins; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Japan; Naphthyridines; Penicillin Resistance; Streptococcus pneumoniae; Time Factors | 2003 |
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Clarithromycin; Enterobacteriaceae; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Penicillin G; Pharyngitis; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis | 2003 |
Antibiotic use profile at paediatric clinics in two transitional countries.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftibuten; Ceftriaxone; Cefuroxime; Cephalosporins; Child; Child, Preschool; Croatia; Data Collection; Developing Countries; Doxycycline; Drug Utilization Review; Gentamicins; Hospital Records; Hospitals, University; Humans; Infant; Leucomycins; Outpatient Clinics, Hospital; Pharmacoepidemiology; Retrospective Studies; Russia | 2004 |
Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefprozil; Cephalosporins; Child; Child, Preschool; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Otitis Media; Quebec; Risk Factors; Time Factors; Treatment Outcome | 2005 |
Gonorrhea treatment guidelines in Canada: 2004 update.
Topics: Anti-Infective Agents; Azithromycin; Canada; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Spectinomycin | 2004 |
Resistant organisms and otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefprozil; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Otitis Media; Risk Assessment; Sensitivity and Specificity; Streptococcus pneumoniae | 2005 |
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Azithromycin; beta-Lactamases; Cefpodoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Humans; In Vitro Techniques; Ketolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Quinolines; Selection, Genetic | 2006 |
Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance.
Topics: Adult; Anti-Infective Agents; Azithromycin; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin Resistance; Spectinomycin; Tetracycline Resistance; United States | 2007 |
In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.
Topics: Anti-Bacterial Agents; Azithromycin; Cephalosporins; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Paratyphoid Fever; Quinolones; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2007 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cephalosporins; Cesarean Section; Drug Therapy, Combination; Female; Humans; Incidence; Pregnancy; Surgical Wound Infection | 2008 |
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Biofilms; Cefepime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; DNA-Binding Proteins; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; MutS DNA Mismatch-Binding Protein; Pseudomonas aeruginosa; Transcription Factors | 2009 |
Resistance to ampicillin, third-generation cephalosporins, ciprofloxacin, co-trimoxazole and azithromycin in clinical isolates of Salmonella enterica subsp. enterica from Germany: real problem or sporadic circumstance?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Germany; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella enterica; Salmonella Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2011 |
Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples.
Topics: Alleles; Anti-Infective Agents; Azithromycin; Cefixime; Cephalosporins; Chromosomes, Bacterial; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillins; Plasmids; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Spectinomycin; Tetracycline | 2013 |
Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; British Columbia; Cephalosporins; Cervix Uteri; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharynx; Rectum; Urethra; Young Adult | 2013 |
[Purulent keratoconjunctivitis due to Neisseria gonorrhoeae and Chlamydia trachomatis coinfection].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Chlamydia trachomatis; Coinfection; Conjunctivitis, Bacterial; Conjunctivitis, Inclusion; Homosexuality, Male; Humans; Injections, Intravenous; Male; Neisseria gonorrhoeae; Polymerase Chain Reaction; Sex Offenses; Sexual Behavior; Staphylococcus aureus | 2013 |
Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
Topics: Alberta; Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gonorrhea; Heterosexuality; Homosexuality, Female; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny; Retrospective Studies | 2013 |
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Switzerland; Young Adult | 2013 |
Comparison of Neisseria gonorrhoeae MICs obtained by Etest and agar dilution for ceftriaxone, cefpodoxime, cefixime and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Cephalosporins; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Urethra | 2013 |
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Phenotype; Switzerland; Tetracycline; Young Adult | 2014 |
Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins.
Topics: Anti-Bacterial Agents; Azithromycin; California; Ceftriaxone; Cephalosporins; Disease Susceptibility; Genotype; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2014 |
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance | 2014 |
Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Cephalosporin Resistance; Cephalosporins; Clinical Protocols; Doxycycline; Drug Therapy, Combination; Female; Gonorrhea; Guideline Adherence; Humans; Male; Neisseria gonorrhoeae; Population Surveillance; Sexual Partners; United States | 2015 |
[Antimicrobal resistance of Neisseria gonorrhoeae strains in Hungary].
Topics: Anti-Bacterial Agents; Azithromycin; Cephalosporins; Drug Resistance, Bacterial; Gonorrhea; Humans; Hungary; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2015 |
Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Gonorrhea; Humans; Neisseria gonorrhoeae; Public Health; Treatment Failure | 2015 |
Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
Topics: Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Azithromycin; Canada; Cephalosporins; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Practice Guidelines as Topic; Retrospective Studies; Treatment Failure | 2015 |
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cephalosporins; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2016 |
Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia.
Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Cross-Sectional Studies; Drug Prescriptions; Female; Health Personnel; Humans; Inappropriate Prescribing; Macrolides; Malaysia; Male; Middle Aged; Patients' Rooms; Penicillins; Practice Patterns, Physicians'; Private Practice; Quinolones; Respiratory Tract Infections | 2016 |
Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Germany, West; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline; Tetracyclines; Treatment Outcome | 2016 |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions.
Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella | 2016 |
Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cefdinir; Cephalosporins; Chromatography, Gas; Dietary Carbohydrates; Fatty Acids, Volatile; Feces; Fermentation; Gastrointestinal Microbiome; Male; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity | 2016 |
Cardiac Arrest in Pediatric Patients Receiving Azithromycin.
Topics: Azithromycin; Cardiopulmonary Resuscitation; Cephalosporins; Cohort Studies; Community-Acquired Infections; Databases, Factual; Female; Heart Arrest; Hospital Mortality; Humans; Male; Multivariate Analysis; Penicillins; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Analysis; Treatment Outcome | 2017 |
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms.
Topics: Anti-Bacterial Agents; Azithromycin; Azo Compounds; beta-Lactamases; Biofilms; Cephalosporins; Chromatography, Liquid; Drug Resistance, Bacterial; Haemophilus influenzae; Mass Spectrometry; Microbial Sensitivity Tests; Nitric Oxide Donors; Nitrogen Oxides; Prodrugs; Proteomics | 2017 |
Cephalosporin-NO-donor prodrug PYRRO-C3D shows β-lactam-mediated activity against Streptococcus pneumoniae biofilms.
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Azo Compounds; Biofilms; Cephalosporins; Nitric Oxide; Nitric Oxide Donors; Penicillinase; Plankton; Prodrugs; Streptococcus pneumoniae | 2017 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; beta-Lactamases; Cephalosporins; China; Ciprofloxacin; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Neisseria gonorrhoeae; Penicillins; Repressor Proteins; Spectinomycin; Tetracycline | 2017 |
Fitz-Hugh-Curtis syndrome.
Topics: Abdomen; Adult; Azithromycin; Cephalosporins; Chlamydia Infections; Female; Hepatitis; Humans; Liver; Pelvic Inflammatory Disease; Peritonitis; Young Adult | 2017 |
Adding Azithromycin to Cephalosporin for Cesarean Delivery Infection Prophylaxis: A Cost-Effectiveness Analysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cephalosporins; Cesarean Section; Cost-Benefit Analysis; Endometritis; Female; Humans; Maternal Mortality; Models, Economic; Postoperative Complications; Pregnancy; Sepsis; Surgical Wound Infection | 2017 |
A Comparison of Real-Time Polymerase Chain Reaction Assays for the Detection of Antimicrobial Resistance Markers and Sequence Typing From Clinical Nucleic Acid Amplification Test Samples and Matched Neisseria gonorrhoeae Culture.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; False Positive Reactions; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Neisseria gonorrhoeae; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity | 2018 |
Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Drug Resistance, Bacterial; Female; Gonorrhea; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Taiwan; Vagina | 2018 |
Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.
Topics: Adolescent; Adult; Aged; Alleles; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Genome, Bacterial; Gonorrhea; Humans; Ireland; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Mutation; Neisseria gonorrhoeae; Phylogeny; RNA, Ribosomal, 23S; Whole Genome Sequencing; Young Adult | 2018 |
Genetic characterization of Shiga toxin producing Escherichia coli belonging to the emerging hybrid pathotype O80:H2 isolated from humans 2010-2017 in Switzerland.
Topics: Adhesins, Bacterial; Adhesins, Escherichia coli; Azithromycin; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Fimbriae Proteins; Genome, Bacterial; Humans; Hydroxamic Acids; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Shiga Toxin; Shiga-Toxigenic Escherichia coli; Switzerland; Virulence Factors | 2018 |
Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoeae isolates from men who have sex with men.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Repressor Proteins; Sequence Analysis, DNA; Spectinomycin; Tetracycline | 2019 |
Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Cephalosporins; Drug Resistance, Bacterial; Evolution, Molecular; Genomics; Genotype; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Phenotype; Promoter Regions, Genetic; RNA, Ribosomal, 23S; United States; Whole Genome Sequencing | 2019 |
Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
Topics: Azithromycin; Cephalosporins; Evolution, Molecular; Gonorrhea; Humans; Neisseria gonorrhoeae; United States | 2020 |
Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.
Topics: Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Codon; Evolution, Molecular; Gonorrhea; Humans; Neisseria gonorrhoeae; United States | 2020 |
A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.
Topics: Adult; Antiretroviral Therapy, Highly Active; Azithromycin; Betacoronavirus; CD4 Lymphocyte Count; Cephalosporins; Chicago; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; HIV Infections; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Serologic Tests; Treatment Outcome | 2020 |
The phenotypic and molecular characteristics of antimicrobial resistance of Salmonella enterica subsp. enterica serovar Typhimurium in Henan Province, China.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Salmonella; Salmonella Infections; Serogroup; Young Adult | 2020 |
Multiplex High-Resolution Melting Assay for Simultaneous Identification of Molecular Markers Associated with Extended-Spectrum Cephalosporins and Azithromycin Resistance in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Cephalosporins; Cost-Benefit Analysis; Data Accuracy; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Limit of Detection; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Transition Temperature; Whole Genome Sequencing | 2020 |
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Real-Time Polymerase Chain Reaction | 2020 |
Community use of antibiotics during the COVID-19 lockdown.
Topics: Adenoviridae; Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Cephalosporins; COVID-19; COVID-19 Drug Treatment; Fluoroquinolones; Humans; Hydroxychloroquine; Incidence; Influenza A virus; Influenza B virus; Influenza, Human; Italy; Macrolides; Pandemics; Penicillins; Physical Distancing; Prescription Drug Overuse; Quarantine; Respiratory Syncytial Viruses; Respiratory Tract Infections; SARS-CoV-2 | 2021 |
Sudden emergence of a
Topics: Anti-Bacterial Agents; Asia; Azithromycin; Cephalosporins; Europe; Gonorrhea; High-Throughput Nucleotide Sequencing; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Norway; Phylogeny; Phylogeography; United States; Whole Genome Sequencing | 2020 |
Markedly Reduced Azithromycin and Ceftriaxone Susceptibility in Commensal Neisseria Species in Clinical Samples From Belgian Men Who Have Sex With Men.
Topics: Anti-Bacterial Agents; Azithromycin; Belgium; Ceftriaxone; Cephalosporins; Gonorrhea; Homosexuality, Male; Humans; Male; Neisseria; Neisseria gonorrhoeae; Sexual and Gender Minorities; Vietnam | 2021 |
Molecular Surveillance and Prediction of Antimicrobial Resistance of Neisseria gonorrhoeae in Northern Alberta, Canada, 2015 to 2018.
Topics: Alberta; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2022 |
Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; China; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae | 2022 |
Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Cephalosporins; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Lopinavir; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome | 2022 |
[Temporal trend of antibiotic use among primary school children in Shanghai, 2017-2020].
Topics: Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; China; Humans; Schools | 2022 |
[The postal code as a "bar code" of antimicrobial resistance].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2022 |
Association of Phylogenomic Relatedness among Neisseria gonorrhoeae Strains with Antimicrobial Resistance, Austria, 2016-2020.
Topics: Anti-Bacterial Agents; Austria; Azithromycin; Cephalosporins; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny | 2022 |
Fish as sentinels of antimicrobial resistant bacteria, epidemic carbapenemase genes, and antibiotics in surface water.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ecosystem; Fishes; Tandem Mass Spectrometry; Wastewater; Water | 2022 |
Genomic Characterization of Salmonella enterica Resistant to Cephalosporin, Quinolones, And Macrolides.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Child; Drug Resistance, Bacterial; Fluoroquinolones; Genomics; Humans; Macrolides; Monobactams; Quinolones; Salmonella enterica | 2023 |